A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA).
about
Treatments for hereditary haemochromatosis: a network meta-analysisDeferasirox for managing iron overload in people with myelodysplastic syndromeReducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectivesImpact of cardiac magnetic resonance imaging in non-ischemic cardiomyopathiesEvaluation of a new tablet formulation of deferasirox to reduce chronic iron overload after long-term blood transfusionsInterventions for hereditary haemochromatosis: an attempted network meta-analysis.Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overloadReal-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.Physiology and pathophysiology of iron in hemoglobin-associated diseases.Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine.Deferasirox: a review of its use for chronic iron overload in patients with non-transfusion-dependent thalassaemia.Clinical pharmacology of deferasirox.Deferasirox nephrotoxicity-the knowns and unknowns.Randomized controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major.Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine.Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions.A complicated disease: what can be done to manage thalassemia major more effectively?Deferasirox for managing iron overload in people with thalassaemia.Increasing prevalence of thalassemia in America: Implications for primary care.Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.Deferiprone for the treatment of transfusional iron overload in thalassemia.Current recommendations for chelation for transfusion-dependent thalassemia.The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major.Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromesFactors independently associated with cardiac troponin I levels in young and healthy adults from the general population.Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients.Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study.Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia.Observational Monitoring of Patients with Aplastic Anemia and Low/Intermediate-1 Risk of Myelodysplastic Syndromes Complicated with Iron Overload.Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
P2860
Q24186874-91D23E87-9AC1-4C70-A727-D416E0565F23Q24193067-1BFE7B62-2354-484B-AD1D-339A51377A02Q26740347-E9AAEC58-3BD0-4673-B04C-352A02A0DD8DQ26765173-3699707E-AAEA-4B6D-BD5C-6C6C9E626BAEQ26765306-C9123BB4-3255-4CE8-93A4-7F17DF3985E6Q30399628-4DF33DAB-F6CB-4F8E-8252-93883637A44CQ35813192-43119AF0-E057-48CA-BA5E-6F91388B4608Q35906193-4AA7075B-5E90-4B2C-9015-A529B8BCFE2AQ37082896-92C0B8B4-D540-4B78-AA8C-560C9175DFF3Q37695691-B1169A3F-BF87-4736-807D-48D52882FA2CQ38219588-C0B2A174-7A43-4DAC-8425-9A7FACF8A263Q38226394-F2564987-BC64-4C65-8FFD-A089806452D2Q38232442-3C85DB99-6E92-4189-AFF4-856FC98F84A9Q38258076-843CFA4E-B960-4935-8A29-B692F15407F7Q38388734-F07E954D-CAE2-4F8C-9FB3-FA17B0435182Q38421726-290A8785-E762-4559-AF22-670050B55B87Q38540491-E4566199-9B7C-4B1F-B634-2494096C5D22Q38607875-26A0A8E0-099D-4DD9-AAD5-363FC5FCDD62Q38624033-7B75175E-F6B4-4271-9391-9FFD9ADF15B2Q38626123-432F4CAF-828D-4B30-924F-21332B5603BAQ38650293-A67E14E4-B0CA-4744-AA1E-1D8ECA233C7EQ38817259-28AD733C-D76D-4BCC-8BA2-57FB2E0B823EQ38836184-1027F014-184D-4F2F-8589-B5858AE37260Q39260564-23FA7DB4-C897-4F91-B550-C90B2229CD29Q39453693-82BD1EAD-925A-4068-B794-5788A07C1EFFQ40617829-9105D1FB-5E81-4572-BE1A-55D883C6D45BQ41562000-E08A7DCD-30D3-44D8-AD1C-C82B0AF6A7B4Q46700826-50814542-3C1F-49F9-AB8D-48454F9421D7Q47771973-0AC57DBA-3FA4-4501-AD90-14949DB72D5FQ47864152-504F1F40-4960-4E43-B593-B06616E9330DQ52575650-16D1DB5A-C14A-4D7B-B2D2-BB88392002A2Q56389520-861646B6-9160-45CE-9443-704FC746B5C0
P2860
A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A 1-year randomized controlled ...... -thalassemia major (CORDELIA).
@en
A 1-year randomized controlled ...... removal in β-thalassemia major
@nl
type
label
A 1-year randomized controlled ...... -thalassemia major (CORDELIA).
@en
A 1-year randomized controlled ...... removal in β-thalassemia major
@nl
prefLabel
A 1-year randomized controlled ...... -thalassemia major (CORDELIA).
@en
A 1-year randomized controlled ...... removal in β-thalassemia major
@nl
P2093
P2860
P1433
P1476
A 1-year randomized controlled ...... β-thalassemia major (CORDELIA)
@en
P2093
Akif Yesilipek
Amal El-Beshlawy
Antonio Piga
CORDELIA study investigators
John B Porter
Khawla M Belhoul
Marianne Weisskopf
Mohsen Elalfy
Tomasz Lawniczek
P2860
P304
P356
10.1182/BLOOD-2013-04-497842
P407
P577
2014-01-02T00:00:00Z